(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced today that company founder, CEO and president, Kathleen Danenberg, will present at the 2011 Gastrointestinal Cancers Symposium in San Francisco, January 20-22.
